Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Contraception: Overview of issues specific to adolescents

Mariam R Chacko, MD
Section Editor
Diane Blake, MD
Deputy Editor
Mary M Torchia, MD


This topic review will provide an overview of issues related to the provision of contraceptive services to adolescent females. Emergency contraception, choosing a contraceptive method, and individual methods of contraception are discussed separately.

(See "Emergency contraception".)

(See "Contraceptive counseling and selection".)

(See "Intrauterine contraception: Devices, candidates, and selection".)

(See "Etonogestrel contraceptive implant".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Dec 2016. | This topic last updated: Tue Nov 15 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Finer LB, Zolna MR. Declines in Unintended Pregnancy in the United States, 2008-2011. N Engl J Med 2016; 374:843.
  2. Kann L, McManus T, Harris WA, et al. Youth Risk Behavior Surveillance - United States, 2015. MMWR Surveill Summ 2016; 65:1.
  3. Trussell J. Contraceptive failure in the United States. Contraception 2011; 83:397.
  4. Daniels K, Daugherty J, Jones J. Current contraceptive status among women aged 15-44: United States, 2011-2013. NCHS Data Brief 2014; :1.
  5. Martinez GM, Abma JC. Sexual Activity, Contraceptive Use, and Childbearing of Teenagers Aged 15-19 in the United States. NCHS Data Brief 2015; :1.
  6. Hatcher RA, Trussel J, Nelson AL, et al. Contraceptive Technology, 20th ed, Ardent Media, Inc, New York 2012.
  7. Nelson AI, Neinstein LS. Contraception. In: Handbook of Adolescent Health Care, Neinstein LS, Gordon CM, Katzman DK, et al. (Eds), Lippincott Williams & Wilkins, 2009. p.389.
  8. Preconception Health and Health Care. Reproductive Life Plan Tool for Health Professionals. www.cdc.gov/preconception/documents/rlphealthproviders.pdf (Accessed on April 10, 2016).
  9. Preconception Health and Health Care. Reproductive Life Plan Worksheet. www.cdc.gov/preconception/documents/reproductivelifeplan-worksheet.pdf (Accessed on April 17, 2016).
  10. Kavanaugh ML, Frohwirth L, Jerman J, et al. Long-acting reversible contraception for adolescents and young adults: patient and provider perspectives. J Pediatr Adolesc Gynecol 2013; 26:86.
  11. Kavanaugh ML, Jerman J, Ethier K, Moskosky S. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities. J Adolesc Health 2013; 52:284.
  12. Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med 2014; 371:1316.
  13. Harper CC, Rocca CH, Thompson KM, et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet 2015; 386:562.
  14. Secura GM, Adams T, Buckel CM, et al. Change in sexual behavior with provision of no-cost contraception. Obstet Gynecol 2014; 123:771.
  15. Thompson KM, Rocca CH, Kohn JE, et al. Public Funding for Contraception, Provider Training, and Use of Highly Effective Contraceptives: A Cluster Randomized Trial. Am J Public Health 2016; 106:541.
  16. Oringanje C, Meremikwu MM, Eko H, et al. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2016; 2:CD005215.
  17. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012; 366:1998.
  18. The Patient Protection and Affordable Care Act. Public Law No. 111-148 (2010). http://www.dol.gov/ebsa/healthreform/ (Accessed on March 22, 2016).
  19. Chuang CH, Mitchell JL, Velott DL, et al. Women's Awareness of Their Contraceptive Benefits Under the Patient Protection and Affordable Care Act. Am J Public Health 2015; 105 Suppl 5:S713.
  20. Society for Adolescent Health and Medicine, American Academy of Pediatrics. Confidentiality Protections for Adolescents and Young Adults in the Health Care Billing and Insurance Claims Process. J Adolesc Health 2016; 58:374.
  21. Guttmacher Institute. State laws and policies. Insurance Coverage of Contraceptives. https://www.guttmacher.org/state-policy/explore/insurance-coverage-contraceptives (Accessed on May 31, 2016).
  22. Emans SJ, Grace E, Woods ER, et al. Adolescents' compliance with the use of oral contraceptives. JAMA 1987; 257:3377.
  23. Chacko MR, Wiemann CM, Buzi RS, et al. Choice of Postpartum Contraception: Factors Predisposing Pregnant Adolescents to Choose Less Effective Methods Over Long-Acting Reversible Contraception. J Adolesc Health 2016; 58:628.
  24. Truehart A, Whitaker A. Contraception for the adolescent patient. Obstet Gynecol Surv 2015; 70:263.
  25. Gordon CM, Pitts SA. Approach to the adolescent requesting contraception. J Clin Endocrinol Metab 2012; 97:9.
  26. WHO, Department of Reproductive Health and Research, Medical eligibility criteria wheel for contraceptive use 2015. www.who.int/reproductivehealth/publications/family_planning/mec-wheel-5th/en (Accessed on April 15, 2016).
  27. Rieder J, Coupey SM. Contraceptive compliance: Personalizing an adolescent’s plan for effective birth control. The Female Patient (Suppl) 2000; :12.
  28. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65:1.
  29. Clarke KE, Kraft JM, Wiener JB, et al. Factors Associated with Contraceptive Use Differ between Younger and Older African-American Female Adolescents. J Pediatr Adolesc Gynecol 2016; 29:448.
  30. Melo J, Peters M, Teal S, Guiahi M. Adolescent and Young Women's Contraceptive Decision-Making Processes: Choosing "The Best Method for Her". J Pediatr Adolesc Gynecol 2015; 28:224.
  31. Nguyen LN, Jamieson MA. Adolescent users of an online contraception selection tool: how user preferences and characteristics differ from those of adults. J Pediatr Adolesc Gynecol 2011; 24:317.
  32. Rubin SE, Felsher M, Korich F, Jacobs AM. Urban Adolescents' and Young Adults' Decision-Making Process around Selection of Intrauterine Contraception. J Pediatr Adolesc Gynecol 2016; 29:234.
  33. Brückner H, Bearman P. After the promise: the STD consequences of adolescent virginity pledges. J Adolesc Health 2005; 36:271.
  34. Ott MA, Sucato GS, Committee on Adolescence. Contraception for adolescents. Pediatrics 2014; 134:e1257.
  35. Committee on Adolescence. Contraception for adolescents. Pediatrics 2014; 134:e1244.
  36. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2012; 120:983.
  37. Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group. Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. Obstet Gynecol 2015; 126:e44.
  38. Usinger KM, Gola SB, Weis M, Smaldone A. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review. J Pediatr Adolesc Gynecol 2016; 29:659.
  39. Rosenstock JR, Peipert JF, Madden T, et al. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol 2012; 120:1298.
  40. Secura GM, Allsworth JE, Madden T, et al. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010; 203:115.e1.
  41. Sivin I, Schmidt F. Effectiveness of IUDs: a review. Contraception 1987; 36:55.
  42. Heinemann K, Reed S, Moehner S, Minh TD. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception 2015; 91:280.
  43. Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65:1.
  44. Alton TM, Brock GN, Yang D, et al. Retrospective review of intrauterine device in adolescent and young women. J Pediatr Adolesc Gynecol 2012; 25:195.
  45. Deans EI, Grimes DA. Intrauterine devices for adolescents: a systematic review. Contraception 2009; 79:418.
  46. Díaz J, Pinto Neto AM, Bahamondes L, et al. Performance of the copper T 200 in parous adolescents: are copper IUDs suitable for these women? Contraception 1993; 48:23.
  47. Birgisson NE, Zhao Q, Secura GM, et al. Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users. J Womens Health (Larchmt) 2015; 24:354.
  48. Scholes D, LaCroix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005; 159:139.
  49. Black box warning added concerning long-term use of Depo-provera contraceptive injection. FDA Talk Paper. November 17, 2004. Available at: www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html (Accessed on December 05, 2007).
  50. Cromer BA, Scholes D, Berenson A, et al. Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine. J Adolesc Health 2006; 39:296.
  51. Harel Z, Wolter K, Gold MA, et al. Inadequate vitamin D status in adolescents with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate injectable contraceptive: a pilot study. J Pediatr Adolesc Gynecol 2010; 23:209.
  52. American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. ACOG Committee Opinion No. 448: Menstrual manipulation for adolescents with disabilities. Obstet Gynecol 2009; 114:1428.
  53. Quint EH, O'Brien RF, COMMITTEE ON ADOLESCENCE, North American Society for Pediatric and Adolescent Gynecology. Menstrual Management for Adolescents With Disabilities. Pediatrics 2016; 138.
  54. Steiner RJ, Liddon N, Swartzendruber AL, et al. Long-Acting Reversible Contraception and Condom Use Among Female US High School Students: Implications for Sexually Transmitted Infection Prevention. JAMA Pediatr 2016; 170:428.
  55. National Institute for Health and Care Excellence. Contraceptive services for under 25s. March 2014. https://www.nice.org.uk/guidance/ph51/chapter/Introduction-scope-and-purpose-of-this-guidance (Accessed on March 29, 2016).
  56. Potter J, Santelli JS. Adolescent contraception: review and guidance for pediatric clinicians. Minerva Pediatr 2015; 67:33.
  57. Gold MA, Sucato GS, Conard LA, et al. Provision of emergency contraception to adolescents. J Adolesc Health 2004; 35:67.
  58. Stancil SL, Miller M, Briggs H, et al. Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications. Pediatrics 2016; 137.
  59. Braverman PK, Breech L, Committee on Adolescence. American Academy of Pediatrics. Clinical report--gynecologic examination for adolescents in the pediatric office setting. Pediatrics 2010; 126:583.
  60. Potter J, Soren K. Long-Acting Reversible Contraception and Condom Use: We Need a Better Message. JAMA Pediatr 2016; 170:417.
  61. United Stated Department of Health and Human Services. Program Guidelines for Project Grants for Family Planning Services. http://www.hhs.gov/opa/title-x-family-planning/title-x-policies/program-guidelines/2001-ofp-guidelines-complete.html#8.1 (Accessed on June 17, 2016).
  62. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356:1013.
  63. Rickert VI, Tiezzi L, Lipshutz J, et al. Depo Now: preventing unintended pregnancies among adolescents and young adults. J Adolesc Health 2007; 40:22.
  64. Kaunitz AM, Darney PD, Ross D, et al. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. Contraception 2009; 80:7.
  65. Trent M, Thompson C, Tomaszewski K. Text Messaging Support for Urban Adolescents and Young Adults Using Injectable Contraception: Outcomes of the DepoText Pilot Trial. J Adolesc Health 2015; 57:100.
  66. Smith C, Gold J, Ngo TD, et al. Mobile phone-based interventions for improving contraception use. Cochrane Database Syst Rev 2015; :CD011159.
  67. Westhoff C, Heartwell S, Edwards S, et al. Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecol 2007; 109:1270.
  68. Polaneczky M, Slap G, Forke C, et al. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med 1994; 331:1201.
  69. Lara-Torre E. "Quick Start", an innovative approach to the combination oral contraceptive pill in adolescents. Is it time to make the switch? J Pediatr Adolesc Gynecol 2004; 17:65.
  70. Castaño PM, Bynum JY, Andrés R, et al. Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial. Obstet Gynecol 2012; 119:14.
  71. Hou MY, Hurwitz S, Kavanagh E, et al. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol 2010; 116:633.
  72. Woods JL, Shew ML, Tu W, et al. Patterns of oral contraceptive pill-taking and condom use among adolescent contraceptive pill users. J Adolesc Health 2006; 39:381.
  73. Moreau C, Bouyer J, Gilbert F, et al. Social, demographic and situational characteristics associated with inconsistent use of oral contraceptives: evidence from France. Perspect Sex Reprod Health 2006; 38:190.
  74. COMMITTEE ON ADOLESCENCE. Condom use by adolescents. Pediatrics 2013; 132:973.